|
1
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Orr B and Edwards RP: Diagnosis and
treatment of ovarian cancer. Hematol Oncol Clin North Am.
32:943–964. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Armbruster S, Coleman RL and Rauh-Hain JA:
Management and treatment of recurrent epithelial ovarian cancer.
Hematol Oncol Clin North Am. 32:965–982. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pignata S, Pisano C, Di Napoli M, Cecere
SC, Tambaro R and Attademo L: Treatment of recurrent epithelial
ovarian cancer. Cancer. 125 (Suppl 24):S4609–S4615. 2019.
View Article : Google Scholar
|
|
5
|
Wang H, Ma D, Wang C, Zhao S and Liu C:
Triptolide inhibits invasion and tumorigenesis of hepatocellular
carcinoma MHCC-97H cells through NF-κB Signaling. Med Sci Monit.
22:1827–1836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim ST, Kim SY, Lee J, Kim K, Park SH,
Park YS, Lim HY, Kang WK and Park JO: Triptolide as a novel agent
in pancreatic cancer: The validation using patient derived
pancreatic tumor cell line. BMC Cancer. 18:11032018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang T, Ding Y, Yang Y, Wang Z, Gao W, Li
D, Wei J and Sun Y: Synergistic antitumour effects of triptolide
plus 10-hydroxycamptothecin onbladder cancer. Biomed Pharmacother.
115:1088992019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Tang L, Li X and Li H: Triptolide
inhibits vascular endothelial growth factor-mediated angiogenesis
in human breast cancer cells. Exp Ther Med. 16:830–836.
2018.PubMed/NCBI
|
|
9
|
Hu H, Luo L, Liu F, Zou D, Zhu S, Tan B
and Chen T: Anti-cancer and sensibilisation effect of triptolide on
human epithelial ovarian cancer. J Cancer. 7:2093–2099. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu H, Huang G, Wang H, Li X, Wang X, Feng
Y, Tan B and Chen T: Inhibition effect of triptolide on human
epithelial ovarian cancer via adjusting cellular immunity and
angiogenesis. Oncol Rep. 39:1191–1196. 2018.PubMed/NCBI
|
|
11
|
Huang G, Hu H, Zhang Y, Zhu Y, Liu J, Tan
B and Chen T: Triptolide sensitizes cisplatin-resistant human
epithelial ovarian cancer by inhibiting the phosphorylation of AKT.
J Cancer. 10:3012–3020. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong YY, Chen HP, Tan BZ, Yu HH and Huang
XS: Triptolide avoids cisplatin resistance and induces apoptosis
via the reactive oxygen species/nuclear factor-κB pathway in
SKOV3PT platinum-resistant human ovarian cancer cells.
Oncol Lett. 6:1084–1092. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu H, Zhu S, Tong Y, Huang G, Tan B and
Yang L: Antitumor activity of triptolide in SKOV3 cells and
SKOV3/DDP in vivo and in vitro. Anticancer Drugs. 31:483–491. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei YM, Wang YH, Xue HQ, Luan ZH, Liu BW
and Ren JH: Triptolide, A potential autophagy modulator. Chin J
Integr Med. 25:233–240. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kocaturk NM, Akkoc Y, Kig C, Bayraktar O,
Gozuacik D and Kutlu O: Autophagy as a molecular target for cancer
treatment. Eur J Pharm Sci. 134:116–137. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Poillet-Perez L and White E: Role of tumor
and host autophagy in cancer metabolism. Genes Dev. 33:610–619.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Denton D and Kumar S: Autophagy-dependent
cell death. Cell Death Differ. 26:605–616. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pietrocola F, Izzo V, Niso-Santano M,
Vacchelli E, Galluzzi L, Maiuri MC and Kroemer G: Regulation of
autophagy by stress-responsive transcription factors. Semin Cancer
Biol. 23:310–322. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao D, Wen X, Liu L, Wang L, Zhou X, Li Y,
Zeng X, He G and Jiang X: Sanshool improves UVB-induced skin
photodamage by targeting JAK2/STAT3-dependent autophagy. Cell Death
Dis. 10:192019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You L, Wang Z, Li H, Shou J, Jing Z, Xie
J, Sui X, Pan H and Han W: The role of STAT3 in autophagy.
Autophagy. 11:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshikawa T, Miyamoto M, Aoyama T, Soyama
H, Goto T, Hirata J, Suzuki A, Nagaoka I, Tsuda H, Furuya K and
Takano M: JAK2/STAT3 pathway as a therapeutic target in ovarian
cancers. Oncol Lett. 15:5772–5780. 2018.PubMed/NCBI
|
|
22
|
Gritsina G, Xiao F, O'Brien SW, Gabbasov
R, Maglaty MA, Xu RH, Thapa RJ, Zhou Y, Nicolas E, Litwin S, et al:
Targeted blockade of JAK/STAT3 signaling inhibits ovarian carcinoma
growth. Mol Cancer Ther. 14:1035–1047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng X, Chen W, Hou H, Li J, Li H, Sun X,
Zhao L and Li X: Ginsenoside 20(S)-Rg3 induced autophagy to inhibit
migration and invasion of ovarian cancer. Biomed Pharmacother.
85:620–626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tai WT, Shiau CW, Chen HL, Liu CY, Lin CS,
Cheng AL, Chen PJ and Chen KF: Mcl-1-dependent activation of Beclin
1 mediates autophagic cell death induced by sorafenib and SC-59 in
hepatocellular carcinoma cells. Cell Death Dis. 4:e4852013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krosch TC, Sangwan V, Banerjee S, Mujumdar
N, Dudeja V, Saluja AK and Vickers SM: Triptolide-mediated cell
death in neuroblastoma occurs by both apoptosis and autophagy
pathways and results in inhibition of nuclear factor-kappa B
activity. Am J Surg. 205:387–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Lu Q, Xie W, Wang Y and Wang G:
Anti-tumor effects of triptolide on angiogenesis and cell apoptosis
in osteosarcoma cells by inducing autophagy via repressing
Wnt/β-Catenin signaling. Biochem Biophys Res Commun. 496:443–449.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Zhao P, Wang X, Wang L, Zhu Y and
Gao W: Triptolide induces glioma cell autophagy and apoptosis via
upregulating the ROS/JNK and downregulating the Akt/mTOR signaling
pathways. Front Oncol. 9:3872019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin G, Li P and Xue Z: Triptolide induces
protective autophagy and apoptosis in human cervical cancer cells
by downregulating Akt/mTOR activation. Oncol Lett. 16:3929–3934.
2018.PubMed/NCBI
|
|
29
|
Kaminskyy VO and Zhivotovsky B: Free
radicals in cross talk between autophagy and apoptosis. Antioxid
Redox Signal. 21:86–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao Y, Wang J, Tian H and Fu GH:
Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a
critical modulator of CYT997-induced autophagy and apoptosis in
gastric cancer. J Exp Clin Cancer Res. 39:1192020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Germain M, Nguyen AP, Le Grand JN, Arbour
N, Vanderluit JL, Park DS, Opferman JT and Slack RS: MCL-1 is a
stress sensor that regulates autophagy in a developmentally
regulated manner. EMBO J. 30:395–407. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R
and Darwiche N: Cell death mechanisms of plant-derived anticancer
drugs: Beyond apoptosis. Apoptosis. 20:1531–1562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma K, Zhang C, Huang MY, Li WY and Hu GQ:
Cinobufagin induces autophagy-mediated cell death in human
osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Oncol Rep. 36:90–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM,
Tsao JW, Juan YN, Chiu HY, Yang JS and Wang CC: Resveratrol-induced
autophagy and apoptosis in cisplatin-resistant human oral cancer
CAR cells: A key role of AMPK and Akt/mTOR signaling. Int J Oncol.
50:873–882. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cooper KF: Till death do us part: The
marriage of autophagy and apoptosis. Oxid Med Cell Longev.
2018:47012752018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fitzwalter BE and Thorburn A: Recent
insights into cell death and autophagy. FEBS J. 282:4279–4288.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bhat P, Kriel J, Shubha Priya B, Basappa,
Shivananju NS and Loos B: Modulating autophagy in cancer therapy:
Advancements and challenges for cancer cell death sensitization.
Biochem Pharmacol. 147:170–182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kriel J and Loos B: The good, the bad and
the autophagosome: Exploring unanswered questions of
autophagy-dependent cell death. Cell Death Differ. 26:640–652.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fulda S and Kögel D: Cell death by
autophagy: Emerging molecular mechanisms and implications for
cancer therapy. Oncogene. 34:5105–5113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cirone M, Gilardini Montani MS, Granato M,
Garufi A, Faggioni A and D'Orazi G: Autophagy manipulation as a
strategy for efficient anticancer therapies: Possible consequences.
J Exp Clin Cancer Res. 38:2622019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Galadari S, Rahman A, Pallichankandy S and
Thayyullathil F: Reactive oxygen species and cancer paradox: To
promote or to suppress? Free Radic Biol Med. 104:144–164. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zou Z, Chang H, Li H and Wang S: Induction
of reactive oxygen species: An emerging approach for cancer
therapy. Apoptosis. 22:1321–1335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao L, Loveless J, Shay C and Teng Y:
Targeting ROS-Mediated crosstalk between autophagy and apoptosis in
cancer. Adv Exp Med Biol. 1260:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fang Y, Li J, Wu Y, Gui J and Shen Y:
Costunolide inhibits the growth of OAW42-A multidrug-resistant
human ovarian cancer cells by activating apoptotic and autophagic
pathways, production of reactive oxygen species (ROS), cleaved
caspase-3 and cleaved caspase-9. Med Sci Monit. 25:3231–3237. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma Z, Bao X and Gu J: Furowanin A-induced
autophagy alleviates apoptosis and promotes cell cycle arrest via
inactivation STAT3/Mcl-1 axis in colorectal cancer. Life Sci.
218:47–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun Q, Lu NN and Feng L: Apigetrin
inhibits gastric cancer progression through inducing apoptosis and
regulating ROS-modulated STAT3/JAK2 pathway. Biochem Biophys Res
Commun. 498:164–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
